Updated CDC Zika Laboratory Testing Guidance
The guidance in this video is from December 2016 and may not be the most current information. Please refer to www.cdc.goc/zikaexternal icon for the most up to date information.
CDC and several state and local health departments are testing for Zika virus. Every day, CDC learns more about Zika. CDC has recently released revised Zika virus laboratory testing guidance. During this COCA Call, clinicians will learn about the updated recommendations in CDC’s Guidance for U.S. Laboratories Testing for Zika Virus Infection and understand their role in testing specimens collected from patients. In addition, subject matter experts from CDC, the American Society for Microbiology, and the Association of Public Health Laboratories will discuss changes to the CDC Trioplex Real-time RT-PCR (rRT-PCR) Assay Emergency Use Authorization, examine the use of non-CDC developed assays, and review recommendations for plaque reduction neutralization testing in Puerto Rico.
Grace Kubin, Ph.D.
Texas Department of State Health Services
Association of Public Health Laboratories
Matthew J. Binnicker, Ph.D., D(ABMM)
Director of Clinical Virology
Associate Professor of Laboratory Medicine and Pathology
American Society for Microbiology
Christy Ottendorfer, Ph.D.
Team Lead, Zika Lab Team Task Force
Emergency Operations Center
Centers for Disease Control and Prevention
At the conclusion of the session, the participant will be able to accomplish the following:
- Describe all available Food and Drug Administration Emergency Use Authorizations for Zika virus assays.
- Discuss Zika virus testing methods, including molecular and antibody detection.
- Explain the role of public health laboratories, clinicians, and health departments in Zika testing and diagnosis.
- Identify Zika virus laboratory testing algorithms and resources.
- Audio conference call on Thursday, 12/01/16: 2:00 - 3:00 PM (Eastern Time)
- Web-on-demand training after 3:00 PM on 12/01/16
- Materials: PowerPoint slide set
“WC2286” for attendees who participate in the live call (must be completed by December 31, 2016)
“WD2286” for attendees who participate in the online presentation (must be completed by December 31, 2018)
- Physician Assistants
- Health Educators
- Other Clinicians
- Contact Information:email@example.com
- Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communications Branch
- Method of Participation:You may participate in the educational activity by viewing the program information above.
- Fees:COCA continuing education credits are free.
CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity provides 1.0 contact hour.
IACET CEU:The Centers for Disease Control and Prevention is authorized by IACET to offer 1.0 CEU's for this program.
CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designed for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-16-215-L04-P and enduring 0387-0000-16-215-H04-P course category.Course Category: This activity has been designated as knowledge-based.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at firstname.lastname@example.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
CPH: The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.
CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.orgexternal icon.
There is no cost for this program.
DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
CDC does not accept commercial support.